Exploring Treatment Strategies for Acute Ischemic Stroke
Study on the Effect of Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
This study looks at different treatment methods for people with acute ischemic stroke to see how they affect recovery and what factors might influence their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nanjing First Hospital, Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT05410457 on ClinicalTrials.gov |
What this trial studies
This observational study collects and analyzes clinical information, examination, and imaging data from patients with acute ischemic stroke who receive various treatment strategies. It aims to identify which clinical biological indicators influence patient prognosis and to compare these indicators across different treatment groups, including thrombolysis and thrombectomy. The study also investigates the relationship between blood pressure changes and clinical outcomes, as well as the correlation between neuroimaging results and other clinical variables. By constructing clinical prediction models, the study seeks to enhance understanding of ischemic stroke progression and treatment efficacy.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been admitted to the hospital for ischemic stroke.
Not a fit: Patients with incomplete clinical information or severe comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and better prognostic assessments for patients with acute ischemic stroke.
How similar studies have performed: Other studies have shown success in identifying prognostic indicators in ischemic stroke, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A) ≥18 years of age; B) hospital admission for ischemic stroke; C) Signed informed consent. Exclusion Criteria: * A) patients with incomplete clinical information; B) hospitalization observation time less than 24 hours; C) recent trauma, severe inflammation, severe liver and kidney dysfunction, progressive malignance and other serious diseases; D) baseline mRS score\>2; E) informed consent is not signed.
Where this trial is running
Nanjing, Jiangsu
- Nanjing First Hospital, Nanjing Medical University — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Qiwen Deng, M.D.
- Email: qiw_deng@163.com
- Phone: +86025-87726218
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.